Open an account

Teleflex

TFX · NYSE

$131.15+$1.47 (+1.13%)TodayMarket closed ·
Prev close $129.68

About TFX

Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Employees
15,500
Headquarters
Wayne, Pennsylvania
Listed
Mar 17, 1980
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
teleflex.com

TFX key statistics

Market cap
5.49B
Price-earnings ratio
0.00
Dividend yield
1.08%
Average volume
757.43K
Volume
485.11K
Open price
$130.51
High today
$131.89
Low today
$129.40
52 Week high
$145.00
52 Week low
$100.18

Teleflex (TFX) at a glance

As of Oct 20, 2026, Teleflex (TFX) shares are priced at $131.15, giving the company a market cap of 5.49B, a price-to-earnings ratio of 0.00 and a dividend yield of 1.08%.

Today the stock has traded between $129.40 and $131.89. The current price is 1.4% above the day's low and 0.6% below its high.

Volume so far is 485.11K shares, below the average of 757.43K shares a day.

Over the past year Teleflex has ranged from $100.18 to $145.00, and now sits 69% of the way up that range.

Teleflex met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.76 per share against an estimate of $1.29.

The average analyst price target is $156.97, 19.7% above the current price, from 12 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

58%of 12 analyst ratings say Buy
  • Buy58.3%
  • Hold41.7%
  • Sell0.0%
Price target · 14 analystsAvg $156.97
Low
$139.38
Now
$131.15
High
$178.50

TFX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 10.6% on average.

  1. Q4 FY99: reported $0.71 per share against an estimate of $0.6986
  2. Q1 FY00: reported $0.70 per share against an estimate of $0.6717
  3. Q2 FY00: reported $0.76 per share against an estimate of $0.7575
  4. Q3 FY00: reported $0.55 per share against an estimate of $0.5575
  5. Q3 FY25: reported $3.67 per share against an estimate of $3.42
  6. Q4 FY25: reported $1.93 per share against an estimate of $3.77
  7. Q1 FY26: reported $1.39 per share against an estimate of $1.22
  8. Q2 FY26: reported $1.76 per share against an estimate of $1.29

TFX news

  • Press releaseBusiness Wire

    Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold

  • Press releaseBusiness Wire

    Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

  • Piero Cingari

    Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today

  • Press releaseBusiness Wire

    Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

  • Press releaseBusiness Wire

    Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

  • Press releaseBusiness Wire

    Teleflex Announces Quarterly Dividend

  • Press releaseBusiness Wire

    Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

  • Press releaseBusiness Wire

    Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.